Cargando…
OR06-1 Cyclophosphamide Depletes Primordial Follicles via the p63 Apoptotic Pathway
Cancer therapies often cause serious side effects, affecting the quality of life for cancer survivors. The ovary can be affected by cancer therapies, causing premature ovarian insufficiency, leading to endocrine dysfunction and infertility. Thus, maintaining ovarian function against cancer treatment...
Autores principales: | Dong, Rosemary, Elesh, Ibrahim, Kim, So-Youn, Xu, Pauline, Yu, Seok-Yeong, Luan, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625660/ http://dx.doi.org/10.1210/jendso/bvac150.1399 |
Ejemplares similares
-
FRI379 The Gonadotoxic Effects Of Cyclophosphamide And Busulfan On Ovaries In CD-1 Mouse Model
por: Thonen, Macy, et al.
Publicado: (2023) -
Oocyte CTR1 is not essential for cisplatin-induced oocyte death of primordial follicle
por: Yu, Seok-Yeong, et al.
Publicado: (2022) -
Melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression
por: Feng, Juan, et al.
Publicado: (2022) -
OR20-06 Kisspeptin as a Biomarker for Pregnancy Complications
por: Phylactou, Maria, et al.
Publicado: (2020) -
Protective effects of a SIRT1 inhibitor on primordial follicle activation and growth induced by cyclophosphamide: insights from a bovine in vitro folliculogenesis system
por: Di Emidio, Giovanna, et al.
Publicado: (2022)